Long COVID
Opinion
JAMA Internal Medicine Editor Recaps 2023’s High-Impact Research
Harvard geriatrician Dr. Sharon K. Inouye highlights research into long COVID, thyroid levels, silicosis, and more.
Conference Coverage
ME/CFS and Long COVID: Research Aims to Identify Treatable, Druggable Pathways
A 2-day research conference sponsored by the US National Institutes of Health highlighted research that points to mechanisms that suggest...
Expert Perspective
Long COVID: New Info on Who Is Most Likely to Get It
People with a history of allergies, anxiety or depression, arthritis, and autoimmune diseases and women are among those who appear more vulnerable...
News
Monoclonal Antibodies: A New Treatment for Long COVID?
Three Florida patients with long COVID made complete — and sudden — recoveries after they were given the monoclonal antibody cocktail casirivimab/...
Latest News
Some reasons to get off the fence about COVID booster
“The body of evidence from all these different studies converge on one single reality — that vaccines reduce the risk of long COVID.”
Latest News
New tests may finally diagnose long COVID
“I was gobsmacked by the results. We’re seeing a massive dysregulation in those four biomarkers. It’s a combination that we showed was predictive...
Conference Coverage
Chest pain with long COVID common but undertreated
“Our current analysis indicates that chest pain continues on for years in many individuals, suggesting that COVID-related chest pain may be...
News
Long COVID and mental illness: New guidance
“Long COVID is real, and mental health conditions do not cause long COVID.”
Article
Sensory comeback: New findings show the path to smell and taste recovery after COVID
“... There are still people suffering from it. ... It really has a significant psychological impact.”
News
Second infection hikes long COVID risk: Expert Q&A
There are people who think, “This is a nothing-burger anymore,” or “It’s not an issue anymore.” It’s still happening with the current variants.